 | • レポートコード：MRC2102QY8207 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の弱毒生ワクチン市場について種類別（子供、成人）、用途別（病院、医療センター、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・弱毒生ワクチン市場の概要 ・世界の主要地域別弱毒生ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の弱毒生ワクチン市場規模2015-2026：種類別（子供、成人） ・世界の弱毒生ワクチン市場規模2015-2026：用途別（病院、医療センター、その他） ・弱毒生ワクチンの米国市場規模2015-2020 ・弱毒生ワクチンのヨーロッパ市場規模2015-2020 ・弱毒生ワクチンの中国市場規模2015-2020 ・弱毒生ワクチンの日本市場規模2015-2020 ・弱毒生ワクチンの東南アジア市場規模2015-2020 ・弱毒生ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・弱毒生ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・弱毒生ワクチンの市場動向・機会・課題 ・調査の結論 |
Live attenuated vaccine refers to the pathogen after formaldehyde treatment, the structure of A subunit (toxic subunit) changes, toxicity weakened, but the activity of B subunit (binding subunit) remains unchanged, that is, the antigenicity of A vaccine. Inoculation into the body will not cause disease, but the pathogen can trigger the body’s immune response, stimulating the body to produce specific memory B cells and memory T cells. It provides long-term or lifelong protection.
Market Analysis and Insights: Global Live Attenuated Vaccine Market
The global Live Attenuated Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Live Attenuated Vaccine Scope and Market Size
The global Live Attenuated Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Live Attenuated Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Live Attenuated Vaccine market is segmented into
Children
Adult
Segment by Application, the Live Attenuated Vaccine market is segmented into
Hospital
Medical Center
Others
The Live Attenuated Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Live Attenuated Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Live Attenuated Vaccine Market Share Analysis
Live Attenuated Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Live Attenuated Vaccine business, the date to enter into the Live Attenuated Vaccine market, Live Attenuated Vaccine product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma (Japan)
CSL Limited (Australia)
Emergent BioSolutions (U.S.)
GlaxoSmithKline (U.K.)
Johnson & Johnson (U.S.)
MedImmune (U.S.)
Merck & Co (U.S.)
Pfizer (U.S.)
Sanofi Pasteur (France)
Serum Institute of India Pvt (India)
1 Live Attenuated Vaccine Market Overview
1.1 Live Attenuated Vaccine Product Scope
1.2 Live Attenuated Vaccine Segment by Type
1.2.1 Global Live Attenuated Vaccine Sales by Type (2020-2026)
1.2.2 Children
1.2.3 Adult
1.3 Live Attenuated Vaccine Segment by Application
1.3.1 Global Live Attenuated Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Others
1.4 Live Attenuated Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Live Attenuated Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Live Attenuated Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Live Attenuated Vaccine Price Trends (2015-2026)
2 Live Attenuated Vaccine Estimate and Forecast by Region
2.1 Global Live Attenuated Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Live Attenuated Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Live Attenuated Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Live Attenuated Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Live Attenuated Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Live Attenuated Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Live Attenuated Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Live Attenuated Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Live Attenuated Vaccine Estimates and Projections (2015-2026)
2.4.3 China Live Attenuated Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Live Attenuated Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Live Attenuated Vaccine Estimates and Projections (2015-2026)
2.4.6 India Live Attenuated Vaccine Estimates and Projections (2015-2026)
3 Global Live Attenuated Vaccine Competition Landscape by Players
3.1 Global Top Live Attenuated Vaccine Players by Sales (2015-2020)
3.2 Global Top Live Attenuated Vaccine Players by Revenue (2015-2020)
3.3 Global Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Attenuated Vaccine as of 2019)
3.4 Global Live Attenuated Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Live Attenuated Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Live Attenuated Vaccine Players (Opinion Leaders)
4 Global Live Attenuated Vaccine Market Size by Type
4.1 Global Live Attenuated Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Live Attenuated Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Live Attenuated Vaccine Price by Type (2015-2020)
4.2 Global Live Attenuated Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Live Attenuated Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Live Attenuated Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Live Attenuated Vaccine Price Forecast by Type (2021-2026)
5 Global Live Attenuated Vaccine Market Size by Application
5.1 Global Live Attenuated Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Live Attenuated Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Live Attenuated Vaccine Price by Application (2015-2020)
5.2 Global Live Attenuated Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Live Attenuated Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Live Attenuated Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Live Attenuated Vaccine Price Forecast by Application (2021-2026)
6 United States Live Attenuated Vaccine Market Facts & Figures
6.1 United States Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
7 Europe Live Attenuated Vaccine Market Facts & Figures
7.1 Europe Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
8 China Live Attenuated Vaccine Market Facts & Figures
8.1 China Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
8.2 China Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
8.3 China Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
9 Japan Live Attenuated Vaccine Market Facts & Figures
9.1 Japan Live Attenuated Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Live Attenuated Vaccine Market Facts & Figures
10.1 Southeast Asia Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
11 India Live Attenuated Vaccine Market Facts & Figures
11.1 India Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
11.2 India Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
11.3 India Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Live Attenuated Vaccine Business
12.1 Astellas Pharma (Japan)
12.1.1 Astellas Pharma (Japan) Corporation Information
12.1.2 Astellas Pharma (Japan) Business Overview
12.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Pharma (Japan) Live Attenuated Vaccine Products Offered
12.1.5 Astellas Pharma (Japan) Recent Development
12.2 CSL Limited (Australia)
12.2.1 CSL Limited (Australia) Corporation Information
12.2.2 CSL Limited (Australia) Business Overview
12.2.3 CSL Limited (Australia) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Limited (Australia) Live Attenuated Vaccine Products Offered
12.2.5 CSL Limited (Australia) Recent Development
12.3 Emergent BioSolutions (U.S.)
12.3.1 Emergent BioSolutions (U.S.) Corporation Information
12.3.2 Emergent BioSolutions (U.S.) Business Overview
12.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Products Offered
12.3.5 Emergent BioSolutions (U.S.) Recent Development
12.4 GlaxoSmithKline (U.K.)
12.4.1 GlaxoSmithKline (U.K.) Corporation Information
12.4.2 GlaxoSmithKline (U.K.) Business Overview
12.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Products Offered
12.4.5 GlaxoSmithKline (U.K.) Recent Development
12.5 Johnson & Johnson (U.S.)
12.5.1 Johnson & Johnson (U.S.) Corporation Information
12.5.2 Johnson & Johnson (U.S.) Business Overview
12.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson (U.S.) Live Attenuated Vaccine Products Offered
12.5.5 Johnson & Johnson (U.S.) Recent Development
12.6 MedImmune (U.S.)
12.6.1 MedImmune (U.S.) Corporation Information
12.6.2 MedImmune (U.S.) Business Overview
12.6.3 MedImmune (U.S.) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 MedImmune (U.S.) Live Attenuated Vaccine Products Offered
12.6.5 MedImmune (U.S.) Recent Development
12.7 Merck & Co (U.S.)
12.7.1 Merck & Co (U.S.) Corporation Information
12.7.2 Merck & Co (U.S.) Business Overview
12.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck & Co (U.S.) Live Attenuated Vaccine Products Offered
12.7.5 Merck & Co (U.S.) Recent Development
12.8 Pfizer (U.S.)
12.8.1 Pfizer (U.S.) Corporation Information
12.8.2 Pfizer (U.S.) Business Overview
12.8.3 Pfizer (U.S.) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer (U.S.) Live Attenuated Vaccine Products Offered
12.8.5 Pfizer (U.S.) Recent Development
12.9 Sanofi Pasteur (France)
12.9.1 Sanofi Pasteur (France) Corporation Information
12.9.2 Sanofi Pasteur (France) Business Overview
12.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Pasteur (France) Live Attenuated Vaccine Products Offered
12.9.5 Sanofi Pasteur (France) Recent Development
12.10 Serum Institute of India Pvt (India)
12.10.1 Serum Institute of India Pvt (India) Corporation Information
12.10.2 Serum Institute of India Pvt (India) Business Overview
12.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Serum Institute of India Pvt (India) Live Attenuated Vaccine Products Offered
12.10.5 Serum Institute of India Pvt (India) Recent Development
13 Live Attenuated Vaccine Manufacturing Cost Analysis
13.1 Live Attenuated Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Live Attenuated Vaccine
13.4 Live Attenuated Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Live Attenuated Vaccine Distributors List
14.3 Live Attenuated Vaccine Customers
15 Market Dynamics
15.1 Live Attenuated Vaccine Market Trends
15.2 Live Attenuated Vaccine Opportunities and Drivers
15.3 Live Attenuated Vaccine Market Challenges
15.4 Live Attenuated Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Live Attenuated Vaccine Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Live Attenuated Vaccine Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Live Attenuated Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Live Attenuated Vaccine Sales (MT) by Region (2015-2020)
Table 5. Global Live Attenuated Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Live Attenuated Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Live Attenuated Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Live Attenuated Vaccine Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Live Attenuated Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Live Attenuated Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Live Attenuated Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Live Attenuated Vaccine (MT) of Key Companies (2015-2020)
Table 13. Global Live Attenuated Vaccine Sales Share by Company (2015-2020)
Table 14. Global Live Attenuated Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Live Attenuated Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Live Attenuated Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Attenuated Vaccine as of 2019)
Table 17. Global Live Attenuated Vaccine Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Live Attenuated Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Live Attenuated Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Live Attenuated Vaccine Players
Table 22. Global Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 23. Global Live Attenuated Vaccine Sales Share by Type (2015-2020)
Table 24. Global Live Attenuated Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Live Attenuated Vaccine Price (MT) by Type (2015-2020)
Table 26. Global Live Attenuated Vaccine Sales Share by Type (2021-2026)
Table 27. Global Live Attenuated Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Live Attenuated Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Live Attenuated Vaccine Price (MT) by Type (2021-2026)
Table 30. Global Live Attenuated Vaccine Sales (MT) by Application (2015-2020)
Table 31. Global Live Attenuated Vaccine Sales Share by Application (2015-2020)
Table 32. Global Live Attenuated Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Live Attenuated Vaccine Price (MT) by Application (2015-2020)
Table 34. Global Live Attenuated Vaccine Sales (MT) by Application (2021-2026)
Table 35. Global Live Attenuated Vaccine Sales Share by Application (2021-2026)
Table 36. Global Live Attenuated Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Live Attenuated Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Live Attenuated Vaccine Price (MT) by Application (2021-2026)
Table 39. United States Live Attenuated Vaccine Sales (MT) by Company (2015-2020)
Table 40. United States Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 42. United States Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Live Attenuated Vaccine Sales (MT) by Application (2015-2020)
Table 44. United States Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Live Attenuated Vaccine Sales (MT) by Company (2015-2020)
Table 46. Europe Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 48. Europe Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Live Attenuated Vaccine Sales (MT) by Application (2015-2020)
Table 50. Europe Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Live Attenuated Vaccine Sales (MT) by Company (2015-2020)
Table 52. China Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 54. China Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Live Attenuated Vaccine Sales (MT) by Application (2015-2020)
Table 56. China Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Live Attenuated Vaccine Sales (MT) by Company (2015-2020)
Table 58. Japan Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 60. Japan Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Live Attenuated Vaccine Sales (MT) by Application (2015-2020)
Table 62. Japan Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Live Attenuated Vaccine Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Live Attenuated Vaccine Sales (MT) by Company (2015-2020)
Table 70. India Live Attenuated Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Live Attenuated Vaccine Sales (MT) by Type (2015-2020)
Table 72. India Live Attenuated Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Live Attenuated Vaccine Sales (MT) by Application (2015-2020)
Table 74. India Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
Table 75. Astellas Pharma (Japan) Corporation Information
Table 76. Astellas Pharma (Japan) Description and Business Overview
Table 77. Astellas Pharma (Japan) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Astellas Pharma (Japan) Live Attenuated Vaccine Product
Table 79. Astellas Pharma (Japan) Recent Development
Table 80. CSL Limited (Australia) Corporation Information
Table 81. CSL Limited (Australia) Description and Business Overview
Table 82. CSL Limited (Australia) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. CSL Limited (Australia) Live Attenuated Vaccine Product
Table 84. CSL Limited (Australia) Recent Development
Table 85. Emergent BioSolutions (U.S.) Corporation Information
Table 86. Emergent BioSolutions (U.S.) Description and Business Overview
Table 87. Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Emergent BioSolutions (U.S.) Live Attenuated Vaccine Product
Table 89. Emergent BioSolutions (U.S.) Recent Development
Table 90. GlaxoSmithKline (U.K.) Corporation Information
Table 91. GlaxoSmithKline (U.K.) Description and Business Overview
Table 92. GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline (U.K.) Live Attenuated Vaccine Product
Table 94. GlaxoSmithKline (U.K.) Recent Development
Table 95. Johnson & Johnson (U.S.) Corporation Information
Table 96. Johnson & Johnson (U.S.) Description and Business Overview
Table 97. Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson (U.S.) Live Attenuated Vaccine Product
Table 99. Johnson & Johnson (U.S.) Recent Development
Table 100. MedImmune (U.S.) Corporation Information
Table 101. MedImmune (U.S.) Description and Business Overview
Table 102. MedImmune (U.S.) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. MedImmune (U.S.) Live Attenuated Vaccine Product
Table 104. MedImmune (U.S.) Recent Development
Table 105. Merck & Co (U.S.) Corporation Information
Table 106. Merck & Co (U.S.) Description and Business Overview
Table 107. Merck & Co (U.S.) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Merck & Co (U.S.) Live Attenuated Vaccine Product
Table 109. Merck & Co (U.S.) Recent Development
Table 110. Pfizer (U.S.) Corporation Information
Table 111. Pfizer (U.S.) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfizer (U.S.) Description and Business Overview
Table 113. Pfizer (U.S.) Live Attenuated Vaccine Product
Table 114. Pfizer (U.S.) Recent Development
Table 115. Sanofi Pasteur (France) Corporation Information
Table 116. Sanofi Pasteur (France) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sanofi Pasteur (France) Description and Business Overview
Table 118. Sanofi Pasteur (France) Live Attenuated Vaccine Product
Table 119. Sanofi Pasteur (France) Recent Development
Table 120. Serum Institute of India Pvt (India) Corporation Information
Table 121. Serum Institute of India Pvt (India) Description and Business Overview
Table 122. Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Serum Institute of India Pvt (India) Live Attenuated Vaccine Product
Table 124. Serum Institute of India Pvt (India) Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Live Attenuated Vaccine Distributors List
Table 128. Live Attenuated Vaccine Customers List
Table 129. Live Attenuated Vaccine Market Key Trends
Table 130. Live Attenuated Vaccine Key Opportunities and Drivers
Table 131. Live Attenuated Vaccine Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Live Attenuated Vaccine Product Picture
Figure 2. Global Live Attenuated Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Live Attenuated Vaccine Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Medical Center Examples
Figure 8. Others Examples
Figure 9. Global Live Attenuated Vaccine Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Live Attenuated Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Live Attenuated Vaccine Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Live Attenuated Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Live Attenuated Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Live Attenuated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Live Attenuated Vaccine Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Live Attenuated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Live Attenuated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Live Attenuated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Live Attenuated Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Live Attenuated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Live Attenuated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Live Attenuated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Live Attenuated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Live Attenuated Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Live Attenuated Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Live Attenuated Vaccine Players Market Share by Revenue in Live Attenuated Vaccine 2015 & 2019
Figure 27. Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Live Attenuated Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Live Attenuated Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Live Attenuated Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Live Attenuated Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Live Attenuated Vaccine Sales Market Share by Type in 2019
Figure 33. United States Live Attenuated Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Live Attenuated Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Live Attenuated Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Live Attenuated Vaccine Sales Market Share by Application in 2019
Figure 37. China Live Attenuated Vaccine Sales Market Share by Company in 2019
Figure 38. China Live Attenuated Vaccine Sales Market Share by Type in 2019
Figure 39. China Live Attenuated Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Live Attenuated Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Live Attenuated Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Live Attenuated Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Live Attenuated Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Live Attenuated Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Live Attenuated Vaccine Sales Market Share by Application in 2019
Figure 46. India Live Attenuated Vaccine Sales Market Share by Company in 2019
Figure 47. India Live Attenuated Vaccine Sales Market Share by Type in 2019
Figure 48. India Live Attenuated Vaccine Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Live Attenuated Vaccine
Figure 51. Manufacturing Process Analysis of Live Attenuated Vaccine
Figure 52. Live Attenuated Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
弱毒生水痘ワクチンの世界市場レポート2020 A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of em…- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- 獣医用ワクチンの世界市場レポート2020 Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccine…
- 生細胞イメージング機器の世界市場レポート2020 Market Analysis and Insights: Global Live Cell Imaging Equipment Market The global Live Cell Imaging Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Live Cell Imaging Equipment Scope and Market Size The global…
- 点鼻ワクチンの世界市場レポート2020 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …